TY - JOUR T1 - Effects of sex hormones on brain GABA and glutamate levels in a cis- and transgender cohort JF - medRxiv DO - 10.1101/2021.10.20.21265242 SP - 2021.10.20.21265242 AU - B Spurny-Dworak AU - P Handschuh AU - M Spies AU - U Kaufmann AU - R Seiger AU - M Klöbl AU - ME Konadu AU - MB Reed AU - V Ritter AU - P Baldinger-Melich AU - W Bogner AU - GS Kranz AU - R Lanzenberger Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/10/26/2021.10.20.21265242.abstract N2 - Sex hormones affect the GABAergic and glutamatergic neurotransmitter system as demonstrated in animal studies. However, human research has mostly been correlational in nature. Here, we aimed at substantiating causal interpretations of the interaction between sex hormones and neurotransmitter function by using magnetic resonance spectroscopy imaging (MRSI) to study the effect of gender-affirming hormone treatment (GHT) in transgender individuals.Fifteen trans men (TM) with a DSM-5 diagnosis of gender dysphoria, and 15 age-matched cisgender women (CW) underwent MRSI before and after at least 12 weeks of GHT. Additionally, sex differences in neurotransmitter levels were evaluated in an independent sample of 80 cisgender men and 79 cisgender women. Mean GABA+ (a combination of GABA and macromolecules) and Glx (a combination of glutamate and glutamine) ratios to total creatine (GABA+/tCr, Glx/tCr) were calculated in five predefined regions-of-interest (hippocampus, insula, pallidum, putamen and thalamus).Linear mixed models analysis revealed a significant measurement by gender identity effect (pcorr. = 0.048) for GABA+/tCr ratios in the hippocampus, with the TM cohort showing decreased GABA+/tCr levels after GHT compared to CW. Moreover, analysis of covariance showed a significant sex difference in insula GABA+/tCr ratios (pcorr. = 0.049), indicating elevated GABA levels in cisgender women compared to cisgender men.Our study demonstrates GHT treatment-induced GABA+/tCr reductions in the hippocampus, indicating hormone receptor activation on GABAergic cells and testosterone-induced neuroplastic processes within the hippocampus. Moreover, elevated GABA levels in the female compared to the male insula highlight the importance of including sex as factor in future MRS studies.Competing Interest StatementR. Lanzenberger received travel grants and/or conference speaker honoraria within the last three years from Bruker BioSpin MR and Heel, and has served as a consultant for Ono Pharmaceutical. He received investigator-initiated research funding from Siemens Healthcare regarding clinical research using PET/MR. He is a shareholder of the start-up company BM Health GmbH since 2019.Funding StatementThis research was funded or in part by the Austrian Science Fund (FWF) [KLI 504 and KLI 516 PI: R. Lanzenberger], Brain and Behavior Research Foundation (formerly NARSAD) Young Investigator grants (23741, PI: M. Spies) and grant number P 30701 to W. Bogner, the Medical Imaging Cluster of the Medical University of Vienna, and by the grant “Interdisciplinary translational brain research cluster (ITHC) with highfield MR” from the Federal Ministry of Science, Research and Economy (BMWFW), Austria. M. Kloebl and M.B. Reed are recipients of a DOC Fellowship of the Austrian Academy of Sciences.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Committee of the Medical University of Vienna gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors ER -